264 related articles for article (PubMed ID: 33432062)
1. Taurocholic acid inhibits the response to interferon-α therapy in patients with HBeAg-positive chronic hepatitis B by impairing CD8
Xun Z; Lin J; Yu Q; Liu C; Huang J; Shang H; Guo J; Ye Y; Wu W; Zeng Y; Wu S; Xu S; Chen T; Chen J; Ou Q
Cell Mol Immunol; 2021 Feb; 18(2):461-471. PubMed ID: 33432062
[TBL] [Abstract][Full Text] [Related]
2. Treatment with telbivudine positively regulates antiviral immune profiles in Chinese patients with chronic hepatitis B.
Ma L; Cai YJ; Yu L; Feng JY; Wang J; Li C; Niu JQ; Jiang YF
Antimicrob Agents Chemother; 2013 Mar; 57(3):1304-11. PubMed ID: 23274669
[TBL] [Abstract][Full Text] [Related]
3. Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B.
Micco L; Peppa D; Loggi E; Schurich A; Jefferson L; Cursaro C; Panno AM; Bernardi M; Brander C; Bihl F; Andreone P; Maini MK
J Hepatol; 2013 Feb; 58(2):225-33. PubMed ID: 23046671
[TBL] [Abstract][Full Text] [Related]
4. [Effect of tenofovir disoproxil fumarate antiviral therapy on virus-specific CD8+T Cells function in patients with chronic hepatitis B].
Duan SP; Zhu LH; Hou LJ; Wang HW; Zhu XW; Hao J
Zhonghua Gan Zang Bing Za Zhi; 2021 May; 29(5):421-426. PubMed ID: 34107578
[No Abstract] [Full Text] [Related]
5. Natural killer cells contribute to hepatic injury and help in viral persistence during progression of hepatitis B e-antigen-negative chronic hepatitis B virus infection.
Ghosh S; Nandi M; Pal S; Mukhopadhyay D; Chakraborty BC; Khatun M; Bhowmick D; Mondal RK; Das S; Das K; Ghosh R; Banerjee S; Santra A; Chatterjee M; Chowdhury A; Datta S
Clin Microbiol Infect; 2016 Aug; 22(8):733.e9-733.e19. PubMed ID: 27208430
[TBL] [Abstract][Full Text] [Related]
6. CD56
Shi A; Zhang X; Xiao F; Zhu L; Yan W; Han M; Luo X; Chen T; Ning Q
J Viral Hepat; 2018 Nov; 25(11):1352-1362. PubMed ID: 29888839
[TBL] [Abstract][Full Text] [Related]
7. TCRγδ(+)CD4(-)CD8(-) T cells suppress the CD8(+) T-cell response to hepatitis B virus peptides, and are associated with viral control in chronic hepatitis B.
Lai Q; Ma S; Ge J; Huang Z; Huang X; Jiang X; Li Y; Zhang M; Zhang X; Sun J; Abbott WG; Hou J
PLoS One; 2014; 9(2):e88475. PubMed ID: 24551107
[TBL] [Abstract][Full Text] [Related]
8. Association among cytokine profiles of innate and adaptive immune responses and clinical-virological features in untreated patients with chronic hepatitis B.
Gu Y; Lian Y; Zheng Q; Huang Z; Gu L; Bi Y; Li J; Huang Y; Wu Y; Chen L; Huang Y
BMC Infect Dis; 2020 Jul; 20(1):509. PubMed ID: 32664850
[TBL] [Abstract][Full Text] [Related]
9. Pegylated interferon α enhances recovery of memory T cells in e antigen positive chronic hepatitis B patients.
Liu YZ; Hou FQ; Ding P; Ren YY; Li SH; Wang GQ
Virol J; 2012 Nov; 9():274. PubMed ID: 23158844
[TBL] [Abstract][Full Text] [Related]
10. Natural Killer Cell Characteristics in Patients With Chronic Hepatitis B Virus (HBV) Infection Are Associated With HBV Surface Antigen Clearance After Combination Treatment With Pegylated Interferon Alfa-2a and Adefovir.
Stelma F; de Niet A; Tempelmans Plat-Sinnige MJ; Jansen L; Takkenberg RB; Reesink HW; Kootstra NA; van Leeuwen EM
J Infect Dis; 2015 Oct; 212(7):1042-51. PubMed ID: 25791117
[TBL] [Abstract][Full Text] [Related]
11. Higher BST2 Expression Promotes the Anti-HBV Effect of IFN-α and BST2 Genetic Variant Predicts PegIFNα Treatment Response of HBeAg-Positive Chronic Hepatitis B Patients.
Chen J; Hou J; Na R; Zhou B; Hou J; Jiang DK
Clin Pharmacol Ther; 2024 Feb; 115(2):361-370. PubMed ID: 38018367
[TBL] [Abstract][Full Text] [Related]
12. Recovery of circulating CD56
Liu N; Liu B; Zhang L; Li H; Chen Z; Luo A; Chen M; Peng M; Yin W; Ren H; Hu P
Int Immunopharmacol; 2018 Sep; 62():59-66. PubMed ID: 29990695
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of NKG2C+ natural killer cells, TLR-2 expression on monocytes and downregulation of regulatory T-cells influence PEG-IFN treatment efficacy in entecavir-suppressed patients with CHB.
Yan W; Wu D; Wang X; Chen T; Lai Q; Zheng Q; Jiang J; Hou J; Han M; Ning Q
Antivir Ther; 2015; 20(6):591-602. PubMed ID: 25814467
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B e antigen induces the expansion of monocytic myeloid-derived suppressor cells to dampen T-cell function in chronic hepatitis B virus infection.
Yang F; Yu X; Zhou C; Mao R; Zhu M; Zhu H; Ma Z; Mitra B; Zhao G; Huang Y; Guo H; Wang B; Zhang J
PLoS Pathog; 2019 Apr; 15(4):e1007690. PubMed ID: 30998767
[TBL] [Abstract][Full Text] [Related]
15. Boosting of Hepatitis B Virus-Specific T Cell Responses After Pegylated-Interferon-α-2a Therapy for Hepatitis B e Antigen-Positive Pediatric Patients.
Ning L; Huang X; Xu Y; Yang G; Yang J; Fu Q; Zhang Q; Liu H; Wu X; Wang Z; Luo K
J Interferon Cytokine Res; 2019 Dec; 39(12):740-751. PubMed ID: 31329012
[TBL] [Abstract][Full Text] [Related]
16. Intrahepatic natural killer cell activation, but not function, is associated with HBsAg levels in patients with HBeAg-negative chronic hepatitis B.
Tjwa ET; Zoutendijk R; van Oord GW; Biesta PJ; Verheij J; Janssen HL; Woltman AM; Boonstra A
Liver Int; 2014 Mar; 34(3):396-404. PubMed ID: 23890390
[TBL] [Abstract][Full Text] [Related]
17. Study on the distribution of CD8+ memory T cell subsets and IFN-γ level during the spontaneous clearance of hepatitis B virus in patients with chronic hepatitis B virus infection.
Ma XJ; Chen XF; Chen WL; Chen R; Huang J; Luo XD; Liao JY; Chen XP
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4675-4679. PubMed ID: 29131246
[TBL] [Abstract][Full Text] [Related]
18. Restoration of TLR3-activated myeloid dendritic cell activity leads to improved natural killer cell function in chronic hepatitis B virus infection.
Tjwa ET; van Oord GW; Biesta PJ; Boonstra A; Janssen HL; Woltman AM
J Virol; 2012 Apr; 86(8):4102-9. PubMed ID: 22318141
[TBL] [Abstract][Full Text] [Related]
19. Enhanced functions of peripheral γδ T cells in chronic hepatitis B infection during interferon α treatment in vivo and in vitro.
Chen M; Hu P; Ling N; Peng H; Lei Y; Hu H; Zhang D; Ren H
PLoS One; 2015; 10(3):e0120086. PubMed ID: 25774808
[TBL] [Abstract][Full Text] [Related]
20. Pegylated Interferon-ɑ (IFN-ɑ) Enhances the Inhibitory Effect of Natural Killer Cells on Regulatory T Cells via IFN-γ in Chronic Hepatitis B.
Yuan W; Huang D; Wu D; Chen Y; Ma K; Han M; Luo X; Yan W; Ning Q
J Infect Dis; 2021 Dec; 224(11):1878-1889. PubMed ID: 33870432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]